Precision cancer mouse models through genome editing with CRISPR-Cas9

Area of Science:

• Genomics
• Cancer Biology
• Biotechnology

Background:

• Cancer genomes exhibit significant complexity, including point mutations, translocations, and chromosomal abnormalities.
• Accurate mouse models are crucial for studying the impact of these genomic alterations.
• Conventional mouse model generation is often time-consuming and labor-intensive.

Purpose of the Study:

• To review the application of CRISPR-Cas9 technology in generating precision cancer mouse models.
• To highlight the advantages and challenges of using CRISPR-Cas9 for genome engineering in mouse models.
• To discuss the potential of these models in advancing cancer research and treatment.

Main Methods:

• Utilizing the clustered regularly interspersed short palindromic repeats (CRISPR)-Cas9 system for genome editing.
• Engineering germline and somatic mouse models with specific genetic alterations.
• Reviewing existing literature on CRISPR-Cas9-mediated mouse model generation for cancer research.

Main Results:

• CRISPR-Cas9 enables efficient and precise genome engineering in mice.
• This technology facilitates the creation of models with point mutations, deletions, and complex chromosomal rearrangements.
• CRISPR-Cas9 significantly accelerates the generation of diverse cancer models compared to traditional methods.

Conclusions:

• CRISPR-Cas9 technology is revolutionizing the creation of precision cancer mouse models.
• These advanced models offer a rapid platform for functional cancer genomics.
• The development of these models is paving the way for precision cancer medicine and improved therapeutic strategies.